PE-backed Emmes buys IDS

Emmes, a portfolio company of Behrman Capital, has acquired Munich-based Institut Dr. Schauerte, a clinical research organization that focuses on follow-up studies.

21 December 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles